Zevra Therapeutics (ZVRA) Prepaid Assets (2014 - 2026)

Zevra Therapeutics has reported Prepaid Assets for 13 years, with the latest figure at $4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 31.28% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 31.28% YoY), and the FY2025 full-year result was $7.0 million, up 72.7% from the prior year.
• Prepaid Assets for Q1 2026 stood at $4.9 million, down from $7.0 million in the prior quarter.
• The five-year high for Prepaid Assets was $7.4 million in Q3 2025, with the low at -$426000.0 in Q1 2022.
• Historically, Prepaid Assets has averaged $2.7 million across 5 years, with a median of $2.1 million in 2024.
• Annual changes were most pronounced in 2022 — Prepaid Assets tumbled 207.85% — and 2023, when it surged 489.91%.
• Zevra Therapeutics' Prepaid Assets stood at $1.7 million in 2022, then increased by 8.06% to $1.8 million in 2023, then soared by 122.15% to $4.1 million in 2024, then soared by 72.7% to $7.0 million in 2025, then decreased by 29.35% to $4.9 million in 2026.
• The last three Prepaid Assets figures came in at $4.9 million (Q1 2026), $7.0 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.